You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
McKesson
Dow
Express Scripts
Baxter

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Patent: 9,056,110

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,056,110
Title:Substituted pyrimidinone-phenyl-pyrimidinyl compounds
Abstract: The present disclosure provides pyrimidinone-phenyl-pyrimidinyl compounds useful in the treatment of p38 kinase mediated diseases, such as lymphoma and inflammatory disease, having the structure of Formula (I): ##STR00001## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are as defined in the detailed description; pharmaceutical compositions comprising at least one of the compounds; and methods for treating p38 kinase mediated diseases using the compound.
Inventor(s): Selness; Shaun R. (Chesterfield, MO), Devadas; Balekudru (Chesterfield, MO), Hockerman; Susan L. (Kirkwood, MO), Monahan; Joseph B. (St. Louis, MO)
Assignee: CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO)
Application Number:13/707,326
Patent Claims:see list of patent claims

Details for Patent 9,056,110

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 001 1997-11-26   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX search
Genentech RITUXAN rituximab SOLUTION;INTRAVENOUS 103705 002 1997-11-26   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX search
Centocor Inc REMICADE infliximab VIAL 103772 001 1998-08-24   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX Orphan search
Immunex ENBREL etanercept VIAL; SUBCUTANEOUS 103795 001 1998-11-02   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX Orphan search
Immunex ENBREL etanercept SYRINGE 103795 002 1998-11-02   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX Orphan search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 001 2001-11-14   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX search
Biovitrum Ab KINERET anakinra VIAL; SUBCUTANEOUS 103950 002 2001-11-14   Start Trial CONFLUENCE LIFE SCIENCES, INC. (St. Louis, MO) 2039-02-26 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Express Scripts
McKesson
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.